Recent advances in bone marrow scanning

European Journal of Nuclear Medicine

Volumn 18, Issue 3, 1991, Pages 203-221

  Reske, S N ^a  

^a UNIVERSITY HOSPITAL DÜSSELDORF   (Germany)

Author keywords

Bone marrow scanning; Immunoscintigraphy; Skeletal metastases; Technetium 99m labelled anti NCA 95 antibodies; Technetium 99m labelled microcolloid

Indexed keywords

INDIUM CHLORIDE IN 111; MICROCOLLOID TC 99M; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY TC 99M; UNCLASSIFIED DRUG;

BONE MARROW SCINTISCANNING; BONE METASTASIS; HUMAN; IMMUNOSCINTIGRAPHY; REVIEW;

ANTIBODIES, MONOCLONAL; ANTIGENS, DIFFERENTIATION, MYELOMONOCYTIC; ANTIGENS, NEOPLASM; BONE MARROW; BONE MARROW DISEASES; BONE NEOPLASMS; HEMATOLOGIC DISEASES; HUMAN; IRON RADIOISOTOPES; MEMBRANE GLYCOPROTEINS; TECHNETIUM;

EID: 0026022373     PISSN: 03406997     EISSN: 16197089     Source Type: Journal    
DOI: 10.1007/BF02262732     Document Type: Review

References (109)

1. Scintigraphic examination of bone and marrow infarcts in sickle cell disorders
2. Monoclonal antibodies against carcinoembryonic antigen (CEA) identifies two new forms of cross-reacting antigens of molecular weight 90000 and 160000 in normal granulocytes
3. Immunszintigraphie des hämatopoetischen Knochenmarks bei Osteomyelofibrose
4. A comparison of the behaviour of In-111- and Fe-59-labeled transferrin on incubation with human and rat reticulocytes
5. The relationship between micrometastases in the bone marrow, histopathologic features of the primary tumour in breast cancer and prognosis
6. Current concepts review: mechanisms of cancer metastasis to bone
7. Ultrastructure of reticulum cells in the bone marrow
8. The blood and the lymphoid organs
9. Carcinoembryonic antigen (CEA) and related antigens in blood cells and hematopoietic tissues
10. Immunohistochemical localization and molecular characteristics of three monoclonal antibody-defined epitopes detectable on carcinoembryonic antigen (CEA)
11. Tc-99m Nanokolloid: klinische Ergebnisse im Einsatz eines neuen Entzündungsmarkers
12. Bone marrow scintigraphy in breast cancer
13. Scintigraphic bone marrow status in acquired immunodeficiency syndrome (AIDS): first results in 22 patients
14. Monoclonal antibodies identify a CEA crossreacting antigen of 95 kD (NCA-95) distinct in antigenity and tissue distribution from the previously described NCA of 55 kD
15. Nonspecific cross reacting antigen is a marker for human polymorphs, macrophages and monocytes
16. Antigenic variants of the nonspecific cross-reacting antigen
17. The value of bone marrow biopsy in breast cancer at the time of first relapse
18. Endocytosis and intracellular digestion
19. Monoclonal antibodies detect occult breast carcinoma metastases in the bone marrow of patients with early stage disease
20. Metabolic fate of In-111 in the rat
21. The clinical use of radionuclide bone marrow imaging
22. Detection of isolated mammary carcinoma cells in marrow of patients with primary breast cancer
23. Structural substrates to bone marrow function
24. Radiopharmaceuticals for spleen and marrow studies
25. Pathophysiologische Grundlagen und Ergebnisse der Nanokolloidszintigraphie bei der Entzündungsdiagnostik
26. Scintigraphy of inflammation with nanometer-sized coloidal tracers
27. MR-Tomographie bei lymphatischen und leukämischen Knochenmarkinfiltrationen
28. Radioimmune imaging of bone marrow in patients with suspected bone metastases from primary breast cancer
29. Quantitative histological studies on age changes in bone
30. Quantitative assessment of erythropoiesis in bone marrow expansion areas using Fe-52
31. Radionuclide imaging of bone marrow
32. Knochenmarkszintigraphie mit Radiokolloiden bei Skelettmetastasen
33. Möglichkeiten und Grenzen der Nanokolloidszintigraphie in der Diagnostik von Infektionen am Bewegungsapparat
34. Simultaneous detection in the bone marrow of mammary cancer metastatic cells and of their labelling index as respective markers of the residual minimum submacroscopic disease and its proliferative conditions
35. Tc-99m nanocolloid bone marrow scintigraphy in prostatic cancer
36. False positive granulocyte scintigraphy in a patient with acute leukemia. Case report
37. Techniques for inhibiting tumor metastases
38. Kombinierte Knochenmark- und Skelettszintigraphie bei ossaeren und myelogenen Erkrankungen
39. Vergleich von Tc-99m HMPAO-markierten Leukozyten und Tc-99m Nanokolloid bei Osteomyelitiden
40. Vergleich der Knochenmarkszintigraphie und Magnetresonanztomographie beim Plasmazytom
41. Unusual bone scintigraphy in chronic myelogenous leukemia — report of a case showing extensive uptake defect
42. In vivo labelling of granulocytes with Tc-99m anti-NCA monoclonal antibodies for imaging inflammation
43. Knochenmetastasen
44. Combined bone marrow and gallium imaging. Differentiation of osteomyelitis and infarction in sickle cell hemoglobinopathy
45. The presence of tumour cells in bone marrow at the time of first recurrence of breast cancer
46. Knochenmarkszintigraphie bei hämatologischen Systemerkrankungen
47. Differentiation of bone and bone marrow infarcts from osteomyelitis in sickle cell disorders
48. Prognostic value of bone marrow biopsy in breast cancer
49. Detecting bone marrow metastases at the time of examining the liver with radiocolloid
50. The value of the bone scan and bone marrow biopsy in staging small cell lung cancer
51. Immunoscintigraphy of inflammatory processes with a Technetium-99m-labeled monoclonal antigranulocyte antibody (MAB BW 250/183)
52. Malignant lymphoma: bone marrow imaging versus biopsy
53. Micrometastases in bone marrow in patients with primary breast cancer: evaluation as an early predictor of bone metastases
54. The fate of bone marrow micrometastases in patients with primary breast cancer
55. Assessment of bone marrow blood flow using positron emission tomography: no relationship with marrow cellularity
56. Radioactive agents for morrow imaging
57. Newer developments in nuclear medicine applicable to hematology
58. A comparison of In-111 with Fe-52 and Tc-99m-sulfur-colloid for bone marrow scanning
59. Bone scanning in metastatic disease
60. Frequency of skeletal metastases as revealed by routinely taken bone marrow biopsies
61. Bone marrow biopsies in patients with undifferentiated carcinoma of nasopharyngeal type
62. Miscellanneous applications of radionuclide imaging: bone marrow
63. Bone marrow immunoscintigraphy. Letter
64. Knochenmarkszintigraphie: Grundlagen und klinische Ergebnisse
65. Symmetric visualization of femoral heads in reticuloendothelial bone marrow scanning in adults: correlation with peripheral expansion of the bone marrow organ
66. Comparison of immunoscintigraphy and colloid scintigraphy of bone marrow (letter)
67. Non-specific cross-reacting antigen (NCA) in the individual maturation stages of myeloic cell series
68. Expression of nonspecific cross-reacting antigen species in myeloid leukemic patients and healthy subjects
69. Lymphoma of the skeleton: scintigraphic evaluation
70. The usefulness of bone marrow scintigraphy in the detection of bone metastasis from prostatic cancer
71. Marrow uptake index (MUI): a quantitative scintigraphic study of bone marrow in aplastic anemia
72. A quantitative study of bone marrow using dynamic bone marrow scintigraphy in acute leukemic patients
73. Phagocytic recognition
74. Ergebnisse der Knochenmarkszintigraphie bei hämatologischen Erkrankungen
75. Detection of micrometastases in patients with primary breast cancer
76. Reduced technetium-99m labelled NCA-95/CEA-antibody uptake in the liver due to gentle antibody reconstitution. Technical note
77. In vivo assessment of phagocytic properties of Kupffer cells
78. Localisation of subacute and chronic inflammatory lesions by means of Tc-99m labelled murine monoclonal anti-NCA-antibodies (abstract)
79. Radioimmunoimaging of bone marrow. Results in patients with breast cancer and skeletal metastases and patients with malignant lymphomas
80. Tc-99m labelled NCA-95/CEA-antibodies (TcNCAA) for immunoscintigraphy of hematopoietic bone marrow in man I. Antibody distribution in normal bone marrow
81. Nachweis des Knochenmarkbefalls beim Mammakarzinom und bei malignen Lymphomen durch Immunszintigraphie des hämatopoetischen Knochenmarks
82. Immunoscintigraphy of bone marrow with Tc-99m labelled NCA-95/CEA antibodies (TcNCAA). Comparison with bone scanning, plane radiographs and HAMA-response (abstract)
83. Incidence and histopathology of metastases of mammary carcinoma in biopsies from the posterior iliac crest
84. Bone and bone marrow scintigraphy in the diagnosis of neoplastic involvement of the skeletal system. A comparative analysis
85. Bone metastases: pathogenesis, treatment and rationale for the use of resorption inhibitors
86. Diagnostic strategies and staging procedures for Hodgkin's lymphoma: bone marrow scintigraphy and magnetic resonance imaging
87. Micrometastatic cancer cells in bone marrow at the time of first recurrence: in vitro detection with anti-cytokeratin and in vivo labelling with anti-17-1A monoclonal antibodies
88. Nuclear hematology: the erythron
89. Endocytosis
90. Histologischer Tumortyp und Knochenmarksmetastasen von Carcinomen der Brustdrüse
91. Extensive pelvic infarction diagnosed by radionuclide skeletal and bone marrow imaging
92. Failure of uptake of radiocolloids by the femoral heads: diagnostic problem. Concise communication
93. A novel Tc-99m labelled antibody for in vivo targeting of granulocytes (abstract)
94. Tc-99m labelled HSA-nanocolloid versus In-111 oxine-labelled granulocytes in detecting skeletal septic process
95. Bone marrow imaging
96. Non-specific cross-reacting antigen in normal and myeloid cells and serum of leukemic patients
97. Clinical evaluation of NCA in patients with chronic myelocytic leukemia
98. Bone marrow investigation with Tc-99m microcolloid and magnetic resonance imaging in patients with malignant myelolymphoproliferative diseases
99. Scintigraphy with nanocolloid Tc-99m in patients with small cell lung cancer, with special reference to bone marrow and hepatic metastasis